308本のエピソード
The Uromigos The Uromigos
-
- 健康／フィットネス
-
-
5.0 • 1件の評価
-
Broadcasting the latest developments in GU cancer
-
Episode 310: Dosing and duration of drugs from a cost perspective
Daniel Goldstein describes his work on this issue.
-
Episode 309: EAU24 Checkmate 274 - OS for adjuvant nivolumab in bladder cancer
In this second part, Matt Galsky describes the OS signal data. We also look into the future.
-
Episode 308: EAU24 IMVIGOR 011 - Outcome of ctDNA negative patients post-cystectomy
Tom, Brian and Matt Galsky review the screening component of this study, presented at EAU24.
-
Episode 307: Bladder-Sparing Approaches Part 2
Michiel Van der Heijden explores the role of radiotherapy and other neoadjuvant and other neoadjuvant combinations to prevent the need for surgery.
-
Episode 306: The Uromigos Paper of the Month - Chemo/Nivo as a bladder sparing approach in UC
Matt Galsky describes his phase 2 study looking at gem/cis/nivo followed by nivo in responders. This potentially avoids cystectomy.
-
Episode 305: FDA and Oncology Clinical Trials
FDA Deputy Oncology Director Dan Suzman described approaches to oncology trials. Tom asks 3 last questions which annoys Brian more than usual.